Antihypertensive drugs and cardiac trophic mechanisms

Area of Science:

• Cardiology
• Pharmacology
• Physiology

Background:

• Hypertension-induced left ventricular hypertrophy (LVH) is linked to increased systolic blood pressure (BP) and wall stress.
• Different antihypertensive drug classes may influence trophic mechanisms beyond BP reduction, affecting LVH outcomes.

Purpose of the Study:

• To investigate the differential effects of various antihypertensive drug classes on left ventricular hypertrophy (LVH).
• To understand how different drug mechanisms influence cardiac mass in hypertensive patients.

Main Methods:

• Comparative analysis of antihypertensive drug classes based on their known effects on BP, wall stress, and neuro-hormonal activity.
• Review of existing literature on the impact of specific drug classes on LVH regression or progression.

Main Results:

• Angiotensin-converting enzyme (ACE) inhibitors consistently promote LVH regression by reducing cardiac growth factors.
• Arterial vasodilators may not cause LVH regression and can even lead to progression due to increased diastolic wall stress and sympathetic/renin activity.
• Other antihypertensive classes show variable effects on LVH, ranging from full regression to none.

Conclusions:

• The choice of antihypertensive medication significantly impacts LVH, with ACE inhibitors showing beneficial effects on cardiac mass.
• Factors such as age and individual reactivity of sympathetic and renin systems influence the response of cardiac mass to BP lowering therapies.